An interventional study of CHIMES Intervention and Standard of Care in Human Immunodeficiency Virus and HIV Infections, sponsored by Emory University. Active, not recruiting at 2 sites in United States. Open to male participants aged 18 Years to 29 Years. Per ClinicalTrials.gov, last updated 2025-11-14.
Sponsored by Emory University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in HIV Infections by Emory University — 4 open to participants now, 6 under way, none of them phase 3. HIV Infections · Emory University.
Among the 19 studies in HIV Infections by Emory University, this one is the 2nd largest by planned enrollment of the 17 interventional ones that give a count, is one of 2 that started in 2020, is one of 9 with no phase, and was the 14th registered.
4,737 studies on the registry are indexed under HIV Infections; 247 are open to participants now.
Browse HIV Infections studies →4 of the 19 studies in HIV Infections by Emory University are open now, in 3 countries. Recruiting first, the newest first:
Emory University · Sites in South Africa
Ages 18+ · Men only · Healthy volunteers
Emory University · Sites in United States
Ages 14–21 · Healthy volunteers
Emory University · Sites in Kenya
Ages 25–49 · Women only · Healthy volunteers
Emory University · Sites in United States
Ages 18–70 · Healthy volunteers
By country, each count listing its studies:
Of the 159 HIV Infections studies recruiting now, 104 (65%) set no upper age limit and 42 (26%) stop at 75 or younger; 31 take children under 18; 60 take healthy volunteers.
This study: 18 Years to 29 Years · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 2 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 850 is above the median of 80 across 3,492 interventional studies indexed under HIV Infections.
Median enrollment 63 across the 17 interventional studies, 60 across the 2 observational. Of the 12 that completed or were terminated, 5 (42%) have results posted.
This tab as a report to print or save as PDF → With an account.
Emory University is the lead sponsor of 1,406 studies on the registry; 224 are open to participants now.
Of its 238 completed or terminated interventional studies of FDA-regulated products, 179 (75%) have results posted.
4 of the studies in HIV Infections by Emory University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04833829Emory UniversityCross-disciplinary HIV Integrated Mental Health Support Intervention | 2026-11 |
| NCT07535346Emory UniversityIntegrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta | 2027-04 |
| NCT07226323Emory UniversityTesting the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa | 2027-07-31 |
| NCT06205368Emory UniversityEvaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men | 2027-09 |
Add all 4 to your calendar (.ics) → With an account.
Among the 19 studies in HIV Infections by Emory University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The proposed project seeks to develop and test an intervention to improve engagement in HIV and mental health care for young Black gay, bisexual and other men who have sex with men (YB-GBMSM) in Ryan White clinics.
Young Black gay, bisexual and other men who have sex with men (YB-GBMSM) are disproportionately impacted by HIV, with suboptimal rates of engagement across the HIV Continuum of Care (HIV-CoC). Mental health (MH) comorbidities contribute to poor HIV care engagement for many YB-GBMSM; however, effective treatment for these conditions is hindered by barriers including logistical challenges, medical mistrust, and MH stigma.
The Ryan White Care act supports integration of HIV and MH services; however, preliminary studies demonstrate low rates of MH referrals and MH care engagement among YB-GBMSM living with HIV, even in these ostensibly integrated care settings. The objective of this study is to develop and implement CHIMES (Cross-disciplinary HIV Integrated with Mental Health Support), a clinic- and provider-level intervention to improve HIV-MH care integration and MH care engagement among YB-GBMSM attending Ryan White clinics.
The rationale for this study is that efforts to improve integration of services, particularly if they are culturally tailored, are likely to increase MH and HIV care engagement for YB-GBMSM. The proposed study will pursue two specific aims: (1) to develop the CHIMES intervention; and (2) to conduct a hybrid type 2 implementation-effectiveness pilot trial of CHIMES in two Health Resources and Services Administration (HRSA)/Ryan White-funded clinics in Atlanta, Georgia - a city in the heart of the Southern HIV epidemic.
For the first aim, the researchers will work collaboratively with provider and patient stakeholders, adapt existing evidence-based interventions, and build on formative data to refine intervention content, informed by the Capability- Opportunity-Motivation-Behavior (COM-B) Model. For the second aim, the researchers will implement CHIMES in the two clinic settings and conduct a mixed-methods assessment in which continuous data collection informed by the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework will be used to evaluate effectiveness and implementation processes.
The effectiveness of the CHIMES intervention will be measured by change in HIV and MH care engagement before, during, and after CHIMES implementation. The researchers will abstract clinic-level aggregate data to characterize change in HIV-CoC and MH care engagement outcomes for YB-GBMSM.
4,737 studies on the registry are indexed under HIV Infections; 247 are open to participants now.
This study's planned enrollment of 850 is above the median of 80 across 3,492 interventional studies indexed under HIV Infections.
Browse HIV Infections studies →Emory University is the lead sponsor of 1,406 studies on the registry; 224 are open to participants now.
Of its 238 completed or terminated interventional studies of FDA-regulated products, 179 (75%) have results posted.
Compared within HIV Infections, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Acquired Immunodeficiency Syndrome. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients visiting one of the study clinics prior to implementation of the CHIMES intervention. The Baseline time period consists of study Months 1 - 12. Data are retroactively abstracted from medical records of patients who had clinic visits that occurred between January 1, 2019 and December 31, 2019.
Behavioral: Standard of Care
Patients visiting one of the study clinics during the Implementation period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 13 - 27.
Behavioral: CHIMES Intervention
Patients visiting one of the study clinics during the Maintenance period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 28 - 33.
Behavioral: CHIMES Intervention
There are six components to the intervention: 1. Posters and other print materials to prompt providers and patients to discuss MH care engagement. 2. Brief verbal scripts to help HIV providers facilitate patient MH engagement and discuss barriers to MH utilization. 3. Expanded MH screening procedures, including at initial intake. 4. Case management, emphasizing MH care engagement. 5. Interactive trainings for all HIV providers on MH needs, screening/treatment, and barriers to MH service utilization specific to YB-GBMSM. 6. Regular case review meetings.
The standard of care practices of referring patients to mental health services of the clinic during Months 1 - 12 of the study.
Number of Mental Health Visits
The number of mental health visits by clinic patients during each study time period.
Time frame: Baseline (Months 1-12) up to Month 33
Percentage of Mental Health Visits by YB-GBMSM
The percentage of mental health visits by YB-GBMSM clinic patients during each study time period.
Time frame: Baseline (Months 1-12) up to Month 33
Number of Patients Attending Two HIV Care Visits
The number of patients who come to two HIV Care visits in a 12 month period, during each study time period.
Time frame: Baseline (Months 1-12) up to Month 33
Number of Patients with HIV RNA Viral Suppression
The number of patients with HIV RNA less than 200 Copies, during each study time period.
Time frame: Baseline (Months 1-12) up to Month 33
Number of Mental Health Care Referrals
The number of referrals to mental health care during a 12 month period, during each study time period.
Time frame: Baseline (Months 1-12) up to Month 33
Percentage of Mental Health Referrals for YB-GBMSM
The percentage of mental health referrals by YB-GBMSM clinic patients during each study time period.
Time frame: Baseline (Months 1-12) up to Month 33
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — De-identified participant data will be made available to other researchers, using established public repositories.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Participant data will be made available for sharing after publication of this study.
Access criteria: Data will be available to other researchers using established public repositories.
Started Nov 2020 (actual). Primary completion is estimated for Nov 2026, 72 months after the start.
Of 393 non-industry interventional studies with no phase under HIV Infections, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 45. This study's planned 72 months is above that.
Counting every sponsor, half of 402 studies reached it within 28 months; a quarter within 16 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.